Does microalbuminuria screening in diabetes prevent complications?
Metadata[+] Show full item record
Screening diabetic patients for microalbuminuria identifies those who may benefit from treatments that delay progression to renal failure (strength of recommendation: B, based on extrapolation from Level 1 treatment studies of patients with microalbuminuria). No research has determined the best method for screening for microalbuminuria, or whether screening in primary care populations will produce better long-term outcomes. No studies have examined the role of microalbuminuria screening after angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) have been instituted for other indications.
Journal of Family Practice, 52(3) 2003: 229-231.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.